Co-Diagnostics, in partnership with CoSara Diagnostics, is accelerating the development of PCR tests for the Bundibugyo virus causing the Ebola outbreak in the Democratic Republic of the Congo and Uganda. This joint strategy aims to meet international demand if the outbreak spreads further or requires localized support. The company is working on both virus-specific and broad Ebola detection assays, with plans to support point-of-care testing. The World Health Organization has declared the outbreak a public health emergency, with over 900 suspected cases and 220 deaths reported, highlighting the urgent need for rapid diagnostic tools.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
Crypto investigator ZachXBT criticized all current hardware wallets as insecure and unreliable for signing transactions or storing significant funds. He highlighted Ledger as particularly problematic due to frequent updates that disrupt basic functio...
